Chronic interstitial nephritis induce by Mesalazine;Néphrite interstitielle chronique au 5-ASA: Mise au point à partir d'un nouveau cas

Nephrologie

Volumn 23, Issue 7, 2002, Pages 343-347

  Laboudi, A ^a   Makdassi, R ^a   Cordonnier, C ^b   Fournier, A ^a   Choukroun, Gabriel ^a,b  

^a Serv de Nephrologie/de Med Interne   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Interstitial nephritis; Mesalazine; Renal failure

Indexed keywords

CREATININE; MESALAZINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; CROHN DISEASE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; MALE; PROGNOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MESALAMINE; NEPHRITIS, INTERSTITIAL;

EID: 0036446984     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stein RB, Hanauer SB. Comparative tolerability of treatments for inflammatory bowel disease. Drug Safety 2000; 23: 429-48.
2. Von Muhlendahl KE. Nephritis from 5-aminosalicylic acid. Dtsch Med Wochenschr 1989; 114: 236.
3. World MJ, Stevens PE, Ashton MA, Rainford D. Mesalazine - Associated interstitial nephritis. Nephrol Dial Transplant 1996; 11: 614-21.
4. Manenti L, De Rosa A, Buzio C. Mesalazine - Associated interstitial nephritis: Twice in the same patient. Nephrol Dial Transplant 1997; 12: 2031.
5. Calvino J, Romero R, Pintos E, Losada E, Novoa D, Guimil D, Mardaras J, Sanchez-Guisande D. Mesalazine - Associated tubulo-interstitial nephritis in inflammatory bowel disease. Clin Nephrol 1998; 49: 265-7.
6. Popoola J, Muller AF, Pollock L, O'donnell P, Carmichael P, Stevens P. Late onset in interstitial nephritis associated with mesalazine treatment. BMJ 1998; 317: 795-7.
7. Thuluvath PJ, Ninkovic M, Calam J, Anderson M. Mesalazine induced interstitial nephritis. Gut 1994; 35: 1493-6.
8. Agharazii M, Marcotte J, Boucher D, Noel R, Lebel M. Chronic interstitial nephritis due to 5-aminosalicylic acid. Am J Nephrol 1999; 19: 373-6.
9. Legoux JL, Labarriere D, Grezard O, Jaltel M, Lagasse JP, Bahallah ML, Maitre F, Causse X. Insuffisance rénale chronique (néphrite interstitielle) sous mésalazine. Gastroenterol Clin Biol 1998; 22: 737-9.
10. De Broe ME, Stolear JC, Nouwen EJ, Elseviers MM. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: Is there a link? Nephrol Dial Transplant 1997; 12: 1839-41.
11. Brouillard M, Gheerbrant JD, Gheysens Y, Fleury D, Devred M, Hazzan M, Colombel JF. Néphrite interstitielle chronique et mėalazine: Trois nouveaux cas? Gastroenterol Clin Biol 1998; 22: 724-6.
12. Henning HV, Meinhold J, Eisenhauer TH, Scheler F. Chronische interstitielle nephritis nachbehandlung mit 5-aminosalicylsäure. Lesr-Zuschriften 1989; 144: 1090.
13. Witte T, Olbricht CJ, Koch KM. Interstitial nephritis associated with 5-aminisalicylic acid. Nephron 1994; 67: 481-2.
14. Margetts PJ, Churchill DN, Alexopoulou I. Interstitial nephritis in patients with inflammatory bowel disease treated with mesalazine. J Clin Gastroenterol 2001; 32: 176-8.
15. Masson EA, Rhodes JM. Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss. Gut 1992; 30: 262-4.
16. Smilde TJ, Van Liebergen FJ, Koolen MI, Gerlag PG, Assmann KJ. Tubulointerstitial nephritis caused by mesalazine (S-ASA). Ned Tijdschr Geneeskd 1994; 138: 2557-61.
17. Skhiri H, Knebelmann B, Martin-Iefevre L, Grunfeld JP. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine. Nephron 1998; 79: 236.
18. Novis BH, Korzets Z, Chen J, Bernheim J. Nephrotic syndrome after treatment with 5-aminisalicylic acid. BMJ 1988; 296: 1442.
19. Moayyedi P, Fletcher S, Harnden P, Axon ATR, Brownjohn A. Mesangiocapillary glomerulonephritis associated with ulcerative colitis: Case report of two patients. Nephrol Dial Transplant 1995; 10: 1923-4.
20. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol 1998; 93: 504-14.
21. Mani V. Mesalazine - Associated interstitial nephritis. Nephrol Dial Transplant 1997; 12: 622-3.
22. Bonnet J. Néphropathie et acide 5-aminosalicylique. Gastroenterol Clin Biol 1998; 22: 663-4.
23. Tonolli-Serabian I, Poet JL, Roux H. Médicaments à action anti-inflammatoire lente. In: Th. Bardin, D. Kuntz. Thérapeutique Rhumatologique. Paris: Flammarion Médecine-sciences, 1995; 1: 35-56.